The effect of the nonionic block copolymer pluronic P85 on gene expression in mouse muscle and antigen-presenting cells

Abstract DNA vaccines can be greatly improved by polymer agents that simultaneously increase transgene expression and activate immunity. We describe here Pluronic P85 (P85), a triblock copolymer of ethylene oxide (EO) and propylene oxide (PO) EO26 –PO40 –EO26 . Using a mouse model we demonstrate tha...

Full description

Saved in:
Bibliographic Details
Published inBiomaterials Vol. 30; no. 6; pp. 1232 - 1245
Main Authors Gaymalov, Zagit Z, Yang, Zhihui, Pisarev, Vladimir M, Alakhov, Valery Yu, Kabanov, Alexander V
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.02.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract DNA vaccines can be greatly improved by polymer agents that simultaneously increase transgene expression and activate immunity. We describe here Pluronic P85 (P85), a triblock copolymer of ethylene oxide (EO) and propylene oxide (PO) EO26 –PO40 –EO26 . Using a mouse model we demonstrate that co-administration of a bacterial plasmid DNA with P85 in a skeletal muscle greatly increases gene expression in the injection site and distant organs, especially the draining lymph nodes and spleen. The reporter expression colocalizes with the specific markers of myocytes and keratinocytes in the muscle, as well as dendritic cells (DCs) and macrophages in the muscle, lymph nodes and spleen. Furthermore, DNA/P85 and P85 alone increase the systemic expansion of CD11c+ (DC), and local expansion of CD11c+ , CD14+ (macrophages) and CD49b+ (natural killer) cell populations. DNA/P85 (but not P85) also increases maturation of local DC (CD11c + CD86+ , CD11c + CD80+ , and CD11c + CD40+ ). We suggest that DNA/P85 promotes the activation and recruitment of the antigen-presenting cells, which further incorporate, express and carry the transgene to the immune system organs.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0142-9612
1878-5905
DOI:10.1016/j.biomaterials.2008.10.064